missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Paritaprevir, MedChemExpress
Description
Paritaprevir (ABT-450) is a potent, orally active and antiviral non-structural protein 3/4A (NS3/4A) protease inhibitor with EC50s of 1 and 0.21 nM against HCV 1a and 1b, respectively. Paritaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.31 μM. Paritaprevir is metabolized primarily by cytochrome P450 (CYP) 3A. The plasma concentration and half-life of Paritaprevir can be enhanced by Ritonavir (a CYP450 inhibitor).
Specifications
Specifications
| Chemical Name or Material | Paritaprevir |
| CAS | 1216941-48-8 |
| Color | White |
| Purity Grade Notes | Research |
| Molecular Formula | C40H43N7O7S |
| Quantity | 50 mg |
| Synonym | ABT-450 Veruprevir |
| Solubility Information | DMSO : ≥ 125 mg/mL (163.21 mM) ∣H2O : ≥ 0.1 mg/mL (0.13 mM) |
| SMILES | O=C([C@]1(NC([C@@]2([H])N3C[C@H](OC4=C(C=CC=C5)C5=C6C(C=CC=C6)=N4)C2)=O)[C@H](/C=C\CCCCC[C@H](NC(C7=NC=C(C)N=C7)=O)C3=O)C1)NS(=O)(C8CC8)=O |
| Molecular Weight (g/mol) | 765.88 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?